... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
oxygen molecular entity >
organooxygen compound >
carbonyl compound >
n-[(2r,4ar,12ar)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
n-[(2r,4ar,12ar)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
n-[(2r,4ar,12ar)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic oxo compound >
carbonyl compound >
n-[(2r,4ar,12ar)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic oxo compound >
carbonyl compound >
n-[(2r,4ar,12ar)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
polyatomic entity >
heteroatomic molecular entity >
halide >
organohalogen compound >
n-[(2r,4ar,12ar)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
halogen molecular entity >
halide >
organohalogen compound >
n-[(2r,4ar,12ar)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organohalogen compound >
n-[(2r,4ar,12ar)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
Preferred term
n-[(2r,4ar,12ar)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
inchi
-
InChI=1S/C25H25ClF3N3O5/c1-32-19-8-7-15(11-22(33)30-13-25(27,28)29)37-21(19)12-36-20-9-6-14(10-17(20)24(32)35)31-23(34)16-4-2-3-5-18(16)26/h2-6,9-10,15,19,21H,7-8,11-13H2,1H3,(H,30,33)(H,31,34)/t15-,19-,21+/m1/s1
inchikey
-
KEGRQPVLAXHQPZ-VMRPVKRXSA-N
smiles
-
CN1[C@@H]2CC[C@@H](O[C@H]2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC=CC=C4Cl)CC(=O)NCC(F)(F)F
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:103036